Latham & Watkins has announced the addition of Lydia Torne as a partner in the firm’s London office, where she will be a key member of the Healthcare & Life Sciences Practice.
With a deep specialization in intellectual property transactions, Torne brings extensive experience in various aspects of the field. Her expertise includes handling complex licensing agreements, facilitating collaborations between businesses, structuring joint ventures, and negotiating consortium agreements. She is skilled at navigating transactions that involve the commercialization and monetization of intellectual property, specifically tailored for firms within the life sciences, healthcare, and digital health industries.
In addition to her transactional work, Torne possesses a well-rounded knowledge of regulatory compliance matters. This includes understanding product classification, managing interactions with healthcare professionals, overseeing clinical trial processes (with a focus on data protection issues), ensuring market access for new products, meeting supply chain requirements, and executing effective marketing strategies. Furthermore, her breadth of knowledge includes pharmacovigilance, which is critical for monitoring the safety of pharmaceutical products.
Before joining Latham & Watkins, Torne worked at Simmons & Simmons, where she honed her skills in intellectual property law. She holds an LLB in Law and French Law from University College London, providing her with a solid foundation in legal principles, as well as a postgraduate diploma in Intellectual Property Law from the prestigious University of Oxford. This combination of education and experience positions Torrne as a leading expert in her field, ready to make significant contributions to the firm and its clients.
KEY QUOTES:
“Lydia is a distinguished practitioner whose ambition and deep sector knowledge align perfectly with our own ambitious goals. Her expertise not only enhances our ability to meet the complex needs of our international clients but also positions us to seize new opportunities and expand our market share as we continue to build our platform.”
Ed Barnett, Office Managing Partner of Latham’s London office
“Lydia is a pivotal addition to our team at a time when demand for sophisticated life sciences representation is at an all-time high. We’ve followed her career for some time and have been consistently impressed by her exceptional skills in global licensing. Transactional activity in life sciences remains robust, with an increasingly complex mix of licensing and M&A. Lydia’s deep experience and outstanding track record further strengthen our global practice, following the recent arrival of Kate Hillier in the Bay Area.”
Robbie McLaren, Global Vice Chair of Latham’s Healthcare & Life Sciences Industry Group, based in London
“The continued growth of our global practice remains a top priority as the industry undergoes significant technological and regulatory change. Lydia’s capabilities complement our existing strengths and position us to handle the most complex and consequential transactions in the industry. She will undoubtedly play a critical role in advancing our practice.”
John Manthei, Global Chair of Latham’s Healthcare & Life Sciences Practice
“I am excited to join the firm and contribute to Latham’s renowned Healthcare & Life Sciences Practice, delivering market-leading life sciences collaborations. The firm’s commitment to innovation and excellence aligns with my own professional values, and I look forward to collaborating with my fantastic new colleagues to continue delivering exceptional service to our clients.”
Lydia Torne
